drug protocol number

WO43571

drug sponsor

Roche

drug study

Giredestrant , Phesgo

drug trial site

King Abdulaziz Medical City NG (Riyadh) , King Fahad Medical City (Riyadh),King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase